Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Pearl Biotechnology Limited Liability Company

Clinical trials sponsored by Beijing Pearl Biotechnology Limited Liability Company, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug cocktail aims to outsmart lung cancer resistance

Disease control Not yet recruiting

This study tests a new drug (ANS014004) combined with a standard targeted therapy (EGFR-TKI) in people with advanced EGFR-mutated non-small cell lung cancer. The goal is to find a safe dose and see if the combination can shrink tumors or stop them from growing, especially when th…

Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated May 17, 2026 08:02 UTC